輸入代號或公司名稱後按 Enter
4109

加捷生醫

0.00 (0.00%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
11.0095成交張數366.67本益比0.80股價淨值比1.82%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q2-0.440.03-0.53-39.7%-3.20%0.19%
2026Q10.1525.0%0.460.1813.6%1.10%3.33%
2025Q40.230.430.2720.4%1.64%3.33%
2025Q30.09827.8%0.080.109.0%0.62%0.22%
2025Q2-0.01-100.5%-0.00-0.01-0.7%-0.04%-0.26%
2025Q10.12-11.4%2.140.1310.1%0.90%15.14%
2024Q4-0.12-107.0%2.16-0.20-15.1%-1.46%17.78%
2024Q30.01-95.2%4.030.033.2%0.22%34.81%
2024Q22.144.232.15142.0%17.12%36.39%
2024Q10.141.950.138.3%1.21%17.68%
2023Q41.751.571.61190.1%16.57%14.82%
2023Q30.20600.7%-0.230.1923.0%2.14%-2.34%
2023Q2-0.14-0.41-0.13-14.7%-1.45%-4.21%
2023Q1-0.25-0.29-0.23-29.1%-2.55%-2.90%
2022Q4-0.05-155.6%-0.06-0.04-5.0%-0.49%-0.61%
2022Q30.03199.0%0.080.022.8%0.27%0.80%
2022Q2-0.020.06-0.01-2.1%-0.16%0.58%
2022Q1-0.020.07-0.02-2.7%-0.22%0.69%
2021Q40.090.060.0810.1%0.91%0.59%
2021Q30.01-85.7%-0.160.010.9%0.06%-1.66%
2021Q2-0.01-0.11-0.00-0.8%-0.05%-1.06%
2021Q1-0.03-0.44-0.03-5.6%-0.33%-4.06%
2020Q4-0.14-0.45-0.10-12.8%-1.27%-3.98%
2020Q30.07-0.510.059.3%0.78%-5.34%
2020Q2-0.34-1854.4%-0.60-0.25-38.4%-3.62%-6.22%
2020Q1-0.04-0.24-0.03-3.4%-0.36%-2.39%
2019Q4-0.20-141.2%-0.35-0.14-16.5%-2.03%-3.49%
2019Q3-0.020.35-0.01-1.9%-0.19%4.42%
2019Q20.020.370.011.5%0.20%4.59%
2019Q1-0.150.02-0.10-11.4%-1.47%0.38%
2018Q40.490.040.4140.9%5.91%0.35%
2018Q30.00-2.92-0.00-0.1%-0.01%-31.30%
2018Q2-0.33-3.14-0.28-25.9%-4.09%-33.40%
2018Q1-0.13-387.2%-2.94-0.10-10.6%-1.52%-30.52%
2017Q4-2.47-3416.1%-2.77-2.07-144.5%-26.01%-28.56%
2017Q3-0.22-0.23-0.19-16.9%-2.07%-2.15%
2017Q2-0.13-816.3%-0.08-0.10-8.2%-1.10%-0.68%
2017Q10.04-62.0%0.070.032.3%0.36%0.54%
2016Q40.070.140.064.1%0.64%
2016Q3-0.07-0.05-4.7%-0.58%